Home › Stocks › CORT › All Fund Holders
CORT — CORCEPT THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 45 · Reported value held: $3.61B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 12.43M | $1.08B | 0.02% | Add |
| Renaissance Technologies history | Q2 2026 | 5.26M | $457.50M | 0.63% | Reduce |
| Vanguard Group history | Q4 2025 | 9.49M | $330.42M | 0.01% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.34M | $290.21M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 2.58M | $224.55M | 0.08% | Add |
| Geode Capital Management history | Q2 2026 | 2.53M | $220.21M | 0.01% | Reduce |
| UBS Group AG history | Q2 2026 | 1.38M | $119.79M | 0.02% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.16M | $100.65M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 1.14M | $98.91M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 883.00K | $76.78M | 0.04% | Reduce |
| Northern Trust Corp history | Q2 2026 | 753.80K | $65.54M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 610.08K | $53.05M | 0.04% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 578.52K | $50.30M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 565.67K | $49.18M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 523.67K | $45.53M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 487.06K | $42.35M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 459.74K | $39.97M | 0.02% | Add |
| Citadel Advisors history | Q2 2026 | 425.70K | $37.02M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 328.56K | $28.57M | 0.00% | Add |
| PSP Investments history | Q2 2026 | 328.22K | $28.54M | 0.07% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 253.18K | $22.65M | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 237.61K | $20.66M | 0.01% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 218.08K | $18.96M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 216.17K | $18.80M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 212.03K | $18.44M | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 191.10K | $16.62M | 0.01% | Reduce |
| Royce & Associates history | Q2 2026 | 133.30K | $11.59M | 0.09% | Reduce |
| Prudential Financial history | Q2 2026 | 99.76K | $8.67M | 0.01% | Add |
| Janus Henderson Group history | Q1 2026 | 164.07K | $6.61M | 0.00% | Add |
| Bridgewater Associates history | Q2 2026 | 57.60K | $5.01M | 0.02% | Add |
| Arrowstreet Capital history | Q1 2026 | 67.97K | $2.74M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 30.91K | $2.69M | 0.00% | Add |
| Wellington Management Group history | Q2 2025 | 33.53K | $2.46M | 0.00% | Reduce |
| Polen Capital Management history | Q3 2025 | 28.36K | $2.36M | 0.01% | Add |
| Balyasny Asset Management history | Q2 2026 | 25.35K | $2.20M | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 22.26K | $1.94M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 11.11K | $965.67K | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 10.10K | $878.20K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 9.75K | $847.85K | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 9.23K | $802.72K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 9.03K | $785.34K | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 5.63K | $489.35K | 0.00% | Reduce |
| Dodge & Cox history | Q1 2023 | 21.53K | $466.30K | 0.00% | New |
| Maverick Capital history | Q1 2023 | 18.66K | $404.11K | 0.01% | New |
| T. Rowe Price Associates history | Q2 2026 | 165.24K | $14.37K | 0.00% | Add |